Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
CD4+ and CD8+ T cell subset distribution in the blood of small-bowel-grafted rats: modification during graft-versus-host disease.
Transpl Int. 1998;11 Suppl 1:S467-71. Unique Identifier : AIDSLINE MED/98329743 Marni A; Forti D; Fulgenzi A; Corsi M; Cazzulani A; Ferrero ME; Department of Surgery Pizzamiglio II, Ospedale Niguarda, Milan,; Italy.
Abstract:
We studied the modifications of blood T cell distribution following small-bowel allografting in rats under different experimental conditions. Group 1: ACI (RT1a) rats were used as small-bowel donors for ACI x Wistar (RT1y) F1 hybrid rats (WAF1) in which graft-versus-host disease (GVHD) developed. Group 2: WAF1 rats were used as small-bowel donors to ACI rats which developed rejection. Group 3: WAF1 rats received small bowel from ACI rats hyperimmunized for 10 days (by grafting them with WAF1 skin) and GVHD developed. Group 4: Wistar rats received small bowel from ACI rats hyperimmunized for 10 days (by Wistar skin) and bidirectional GVHD and rejection were assured. A second set of the same groups which were continuously administered with cyclosporine (15 mg/kg per day s.c. for 15 consecutive days) was also studied. Recipient peripheral blood lymphocytes, obtained at 7 and 15 days following small-bowel transplantation, were stained with monoclonal antibodies anti-rat CD4 and CD8 and then analyzed in an automated flow cytometer. A significant major reduction of CD4+/CD8+ T cell ratios was shown in rats that developed simultaneous GVHD and rejection with respect to ungrafted rats.
Keywords: JOURNAL ARTICLE Animal *CD4-CD8 Ratio Graft vs Host Disease/*BLOOD/IMMUNOLOGY Graft Rejection/*BLOOD/IMMUNOLOGY Intestine, Small/*IMMUNOLOGY/*TRANSPLANTATION Male Rats Rats, Inbred ACI Rats, Wistar 990228
A9920994
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.